GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Riken Vitamin Co 4526.T · JPY

Consumer Staples · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

3,745

+5.05%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥96.30bn

FY2017FY2026

Net income

¥7.04bn

FY2017FY2026

Free cash flow

¥925.0m

FY2017FY2026

Shareholders' equity

¥83.34bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥96.30bn¥95.58bn¥91.48bn¥88.75bn¥79.23bn¥77.72bn¥82.97bn¥89.89bn¥89.52bn¥87.18bn
Gross profit¥29.77bn¥31.27bn¥29.89bn¥27.24bn¥25.57bn¥22.01bn¥27.46bn¥26.38bn¥27.09bn¥27.33bn
Research and development——¥3.31bn¥3.22bn¥2.99bn¥3.09bn¥3.09bn¥2.87bn¥2.90bn¥2.79bn
Operating income¥6.90bn¥8.72bn¥9.37bn¥7.18bn¥5.84bn¥1.37bn¥6.39bn¥4.58bn¥5.42bn¥7.06bn
Net income¥7.04bn¥9.39bn¥8.76bn¥6.41bn¥21.58bn−¥1.62bn−¥7.85bn¥3.95bn¥5.64bn¥4.33bn
Diluted earnings per share241.48318.25288.38195.37657.81-49.33-239.40120.43172.05132.08

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥116.39bn¥113.00bn¥118.78bn¥105.22bn¥102.66bn¥106.53bn¥101.85bn¥111.39bn¥111.55bn¥109.65bn
Cash and short-term investments¥20.07bn¥22.30bn¥23.38bn¥19.16bn¥17.30bn¥19.23bn¥14.54bn¥16.59bn¥15.91bn¥18.02bn
Total liabilities¥33.01bn¥33.80bn¥42.13bn¥33.85bn¥36.12bn¥59.86bn¥55.06bn¥49.77bn¥51.43bn¥55.73bn
Debt¥7.14bn¥9.98bn¥16.09bn¥15.71bn¥17.57bn¥25.49bn¥23.22bn¥26.11bn¥26.49bn¥33.15bn
Shareholders' equity¥83.34bn¥79.16bn¥76.61bn¥71.34bn¥66.52bn¥46.16bn¥46.30bn¥61.14bn¥59.65bn¥53.38bn
Shares outstanding29m30m30m33m33m33m33m33m33m33m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥5.96bn¥7.89bn¥10.45bn¥7.83bn¥6.82bn¥7.63bn¥5.85bn¥6.69bn¥5.75bn¥8.13bn
Capital spending−¥5.04bn−¥4.77bn−¥3.03bn−¥2.17bn−¥3.38bn−¥3.77bn−¥5.39bn−¥3.97bn−¥3.04bn−¥2.89bn
Free cash flow¥925.0m¥3.12bn¥7.42bn¥5.67bn¥3.44bn¥3.85bn¥464.0m¥2.71bn¥2.71bn¥5.24bn
Dividends paid−¥3.24bn−¥2.78bn−¥2.19bn−¥1.58bn−¥1.39bn−¥1.41bn−¥1.38bn−¥1.25bn−¥1.07bn−¥1.28bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥25.13bn¥23.80bn¥25.24bn¥24.01bn¥23.26bn¥22.73bn¥25.70bn¥23.52bn
Gross profit¥8.09bn¥6.93bn¥7.47bn¥7.64bn¥7.72bn¥6.94bn¥8.58bn¥7.72bn
Operating income¥2.25bn¥1.19bn¥1.62bn¥1.73bn¥2.37bn¥1.18bn¥2.92bn¥2.10bn
Net income¥1.87bn¥1.09bn¥2.59bn¥1.54bn¥1.82bn¥3.56bn¥2.58bn¥885.0m
Diluted earnings per share64.1437.3187.6952.1061.86120.5084.9529.15
Total assets¥117.34bn¥116.39bn¥116.69bn¥112.81bn¥112.78bn¥113.00bn¥116.68bn¥115.04bn
Cash and short-term investments¥17.91bn¥20.07bn¥17.68bn¥17.32bn¥20.05bn¥22.30bn¥18.67bn¥22.65bn
Debt¥2.23bn¥7.14bn¥2.98bn¥8.66bn¥3.62bn¥9.93bn¥2.89bn¥14.52bn
Shareholders' equity¥84.36bn¥83.34bn¥81.94bn¥80.64bn¥79.02bn¥79.16bn¥80.09bn¥78.09bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.8%4.4%0.9%
Operating income-1.3%38.2%1.4%
Net income3.1%—5.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin31.8%31.8%31.3%31.0%
Operating margin8.1%8.6%7.4%7.1%
Net margin8.6%8.5%9.7%6.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings15.19.38.511.42.9-34.5-5.716.810.016.5
Price to sales1.10.90.80.80.80.70.50.70.60.8

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year55.00163.5091.0066.5048.0042.0042.7539.25
  • 2-for-1 split · 30 Mar 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.